According to the research report, the global dietarysupplements market size is expected to touch USD 317.04 Billion by 2030, from USD 152.95 Billion in 2021, growing with a significant CAGR of 8.4% from 2022 to 2030.
The dietary supplements market report
offers a comprehensive study of the current state expected at the major
drivers, market strategies, and key vendors’ growth. The report presents
energetic visions to conclude and study the market size, market hopes, and
competitive surroundings. The research also focuses on the important
achievements of the market, research & development, and regional growth of
the leading competitors operating in the market. The current trends of the
global dietary supplements market in conjunction with the geographical
landscape of this vertical have also been included in this report.
The report offers intricate dynamics about
different aspects of the global dietary supplements market, which aids
companies operating in the market in making strategic development decisions.
The study also elaborates on significant changes that are highly anticipated to
configure growth of the global dietary supplements market during the forecast
period. It also includes a key indicator assessment that highlights growth
prospects of this market and estimates statistics related to growth of the
market in terms of value (US$ Mn) and volume (tons).
Sample
Link @ https://www.precedenceresearch.com/sample/1211
Report Highlights | Details |
Market Size | US$ 317.04 Billion by 2030 |
Growth Rate | CAGR of 8.4% From 2022 to 2030 |
Base Year | 2021 |
Historic Data | 2017 to 2021 |
Forecast Period | 2022 to 2030 |
Segments Covered | Type, Form, Application, End User |
Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
This study covers a detailed segmentation
of the global dietary supplements market, along with key information and a
competition outlook. The report mentions company profiles of players that are
currently dominating the global dietary supplements market, wherein various
developments, expansions, and winning strategies practiced and implemented by
leading players have been presented in detail.
Key Players
- Bayer
- NBTY Inc
- Bionova Lifesciences
- Nu Skin Enterprises
- Carlyle Group
- Pfizer
- Arkopharma Laboratoires Pharmaceutiques
- Glanbia
- Herbalife International
- Abbott Laboratories
- GlaxoSmithKline
- Nature’s Sunshine Forms
- Amway
- Archer Daniels Midland
Market Segmentation
- Vitamins
- Minerals
- Fibers & Specialty Carbohydrates
- Omega Fatty Acids
- Botanicals
- Proteins & Amino Acids
- Others
By Form
- Capsules
- Tablets
- Gummies
- Soft gels
- Liquids
- Powders
- Others
By Application
- General Health
- Energy & Weight Management
- Gastrointestinal Health
- Diabetes
- Bone & Joint Health
- Immunity
- Cardiac Health
- Anti-cancer
- Others
By End User
- Geriatric
- Adults
- Children
- Infants
By Type
- OTC
- Prescribed
By Distribution Channel
- Offline
- Hypermarkets/Supermarkets
- Pharmacies
- Specialty Stores
- Practioner
- Others
- Online
By Function
- Additional supplements
- Medicinal supplements
- Sports nutrition
By Geography
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- United Kingdom
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of Middle East & Africa
Research Methodology
The research methodology adopted by
analysts for compiling the global dietary supplements market report is based on
detailed primary as well as secondary research. With the help of in-depth
insights of the market-affiliated information that is obtained and legitimated
by market-admissible resources, analysts have offered riveting observations and
authentic forecasts for the global market.
During the primary research phase, analysts
interviewed market stakeholders, investors, brand managers, vice presidents,
and sales and marketing managers. Based on data obtained through interviews of
genuine resources, analysts have emphasized the changing scenario of the global
market.
For secondary research, analysts
scrutinized numerous annual report publications, white papers, market
association publications, and company websites to obtain the necessary
understanding of the global dietary supplements market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Dietary Supplements Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
Chapter 5. COVID 19 Impact on Dietary Supplements Market
5.1. Covid-19: Dietary Supplements Industry Impact
5.2. Dietary Supplements Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Dietary Supplements Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Dietary Supplements Market Players to deal with Covid-19 Pandemic Scenario
Chapter 6. Dietary Supplements Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Rising health concerns and the changing lifestyles
6.1.1.2. Growth in the number of sports complexes and gymnasiums
6.1.2. Market Restraints
6.1.2.1. Rising demand for organic food
6.1.3. Market Opportunities
6.1.3.1. Emerging applications
Chapter 7. Global Dietary Supplements Market: Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Dietary Supplements Market Revenue by Market Players (2017 - 2020)
7.1.1.2. Dietary Supplements Market Revenue Market Share by Market Players (2017 - 2020)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users
Chapter 8. Global Dietary Supplements Market, By Type
8.1. Dietary Supplements Market, by Type, 2017-2030
8.1.1. Vitamins
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Minerals
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Fibers & Specialty Carbohydrates
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Omega Fatty Acids Botanicals
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Proteins & Amino Acids
8.1.5.1. Market Revenue and Forecast (2017-2030)
8.1.6. Others
8.1.6.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Dietary Supplements Market, By Applications
9.1. Dietary Supplements Market, by Applications, 2017-2030
9.1.1. General Health
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Energy & Weight Management
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Gastrointestinal Health
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Diabetes
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Bone & Joint Health
9.1.5.1. Market Revenue and Forecast (2017-2030)
9.1.6. Immunity
9.1.6.1. Market Revenue and Forecast (2017-2030)
9.1.7. Cardiac Health
9.1.7.1. Market Revenue and Forecast (2017-2030)
9.1.8. Anti-cancer
9.1.8.1. Market Revenue and Forecast (2017-2030)
9.1.9. Others
9.1.9.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Dietary Supplements Market, By Form
10.1. Dietary Supplements Market, by Form, 2017-2030
10.1.1. Capsules
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Tablets
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Gummies
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Soft gels
10.1.4.1. Market Revenue and Forecast (2017-2030)
10.1.5. Liquids
10.1.5.1. Market Revenue and Forecast (2017-2030)
10.1.6. Powders
10.1.6.1. Market Revenue and Forecast (2017-2030)
10.1.7. Others
10.1.7.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Dietary Supplements Market, By End user
11.1. Dietary Supplements Market, by End user, 2017-2030
11.1.1. Geriatric
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Adults
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Children
11.1.3.1. Market Revenue and Forecast (2017-2030)
11.1.4. Infants
11.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Dietary Supplements Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue Forecast by Type(2017-2030)
12.1.2. Market Revenue Forecast by Application (2017-2030)
12.1.3. Market Revenue Forecast by Form (2017-2030)
12.1.4. Market Revenue Forecast by End user (2017-2030)
12.1.5. U.S
12.1.5.1. Market Revenue Forecast (2017-2030)
12.1.6. Canada
12.1.6.1. Market Revenue Forecast (2017-2030)
12.2. Europe
12.2.1. Market Revenue Forecast by Type (2017-2030)
12.2.2. Market Revenue Forecast by Application (2017-2030)
12.2.3. Market Revenue Forecast by Form (2017-2030)
12.2.4. Market Revenue Forecast by End user (2017-2030)
12.2.5. UK
12.2.5.1. Market Revenue Forecast (2017-2030)
12.2.6. Germany
12.2.6.1. Market Revenue Forecast (2017-2030)
12.2.7. France
12.2.7.1. Market Revenue Forecast (2017-2030)
12.2.8. Rest of EU
12.2.8.1. Market Revenue Forecast (2017-2030)
12.3. Asia Pacific (APAC)
12.3.1. Market Revenue Forecast by Type (2017-2030)
12.3.2. Market Revenue Forecast by Application (2017-2030)
12.3.3. Market Revenue Forecast by Form (2017-2030)
12.3.4. Market Revenue Forecast by End user (2017-2030)
12.3.5. China
12.3.5.1. Market Revenue Forecast (2017-2030)
12.3.6. India
12.3.6.1. Market Revenue Forecast (2017-2030)
12.3.7. Japan
12.3.7.1. Market Revenue Forecast (2017-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue Forecast (2017-2030)
12.4. LATAM
12.4.1. Market Revenue Forecast by Type (2017-2030)
12.4.2. Market Revenue Forecast by Application (2017-2030)
12.4.3. Market Revenue Forecast by Form (2017-2030)
12.4.4. Market Revenue Forecast by End user (2017-2030)
12.4.5. Brazil
12.4.5.1. Market Revenue Forecast (2017-2030)
12.4.6. Rest of LATAM
12.4.6.1. Market Revenue Forecast (2017-2030)
12.5. Middle East and Africa (MEA)
12.5.1. Market Revenue Forecast by Type (2017-2030)
12.5.2. Market Revenue Forecast by Application (2017-2030)
12.5.3. Market Revenue Forecast by Form (2017-2030)
12.5.4. Market Revenue Forecast by End user (2017-2030)
12.5.5. GCC
12.5.5.1. Market Revenue Forecast (2017-2030)
12.5.6. North Africa
12.5.6.1. Market Revenue Forecast (2017-2030)
12.5.7. South Africa
12.5.7.1. Market Revenue Forecast (2017-2030)
12.5.8. Rest of MEA
12.5.8.1. Market Revenue Forecast (2017-2030)
Chapter 13. Company Profiles
13.1. Bayer
13.1.1. Company Overview, Business Information, Regional Presence
13.1.2. Product Portfolio Analysis
13.1.2.1. Product Details, Specification, Application
13.1.3. Revenue, Price, and Gross Margin (2017-2020)
13.1.4. Recent Developments and Strategies
13.2. NBTY Inc
13.2.1. Company Overview, Business Information, Regional Presence
13.2.2. Product Portfolio Analysis
13.2.2.1. Product Details, Specification, Application
13.2.3. Revenue, Price, and Gross Margin (2017-2020)
13.2.4. Recent Developments and Strategies
13.3. Bionova Lifesciences
13.3.1. Company Overview, Business Information, Regional Presence
13.3.2. Product Portfolio Analysis
13.3.2.1. Product Details, Specification, Application
13.3.3. Revenue, Price, and Gross Margin (2017-2020)
13.3.4. Recent Developments and Strategies
13.4. Nu Skin Enterprises
13.4.1. Company Overview, Business Information, Regional Presence
13.4.2. Product Portfolio Analysis
13.4.2.1. Product Details, Specification, Application
13.4.3. Revenue, Price, and Gross Margin (2017-2020)
13.4.4. Recent Developments and Strategies
13.5. Carlyle Group
13.5.1. Company Overview, Business Information, Regional Presence
13.5.2. Product Portfolio Analysis
13.5.2.1. Product Details, Specification, Application
13.5.3. Revenue, Price, and Gross Margin (2017-2020)
13.5.4. Recent Developments and Strategies
13.6. Pfizer
13.6.1. Company Overview, Business Information, Regional Presence
13.6.2. Product Portfolio Analysis
13.6.2.1. Product Details, Specification, Application
13.6.3. Revenue, Price, and Gross Margin (2017-2020)
13.6.4. Recent Developments and Strategies
13.7. Arkopharma Laboratoires Pharmaceutiques
13.7.1. Company Overview, Business Information, Regional Presence
13.7.2. Product Portfolio Analysis
13.7.2.1. Product Details, Specification, Application
13.7.3. Revenue, Price, and Gross Margin (2017-2020)
13.7.4. Recent Developments and Strategies
13.8. Glanbia
13.8.1. Company Overview, Business Information, Regional Presence
13.8.2. Product Portfolio Analysis
13.8.2.1. Product Details, Specification, Application
13.8.3. Revenue, Price, and Gross Margin (2017-2020)
13.8.4. Recent Developments and Strategies
13.9. Herbalife International
13.9.1. Company Overview, Business Information, Regional Presence
13.9.2. Product Portfolio Analysis
13.9.2.1. Product Details, Specification, Application
13.9.3. Revenue, Price, and Gross Margin (2017-2020)
13.9.4. Recent Developments and Strategies
13.10. Abbott Laboratories
13.10.1. Company Overview, Business Information, Regional Presence
13.10.2. Product Portfolio Analysis
13.10.2.1. Product Details, Specification, Application
13.10.3. Revenue, Price, and Gross Margin (2017-2020)
13.10.4. Recent Developments and Strategies
13.11. GlaxoSmithKline
13.11.1. Company Overview, Business Information, Regional Presence
13.11.2. Product Portfolio Analysis
13.11.2.1. Product Details, Specification, Application
13.11.3. Revenue, Price, and Gross Margin (2017-2020)
13.11.4. Recent Developments and Strategies
13.12. Nature’s Sunshine Forms
13.12.1. Company Overview, Business Information, Regional Presence
13.12.2. Product Portfolio Analysis
13.12.2.1. Product Details, Specification, Application
13.12.3. Revenue, Price, and Gross Margin (2017-2020)
13.12.4. Recent Developments and Strategies
13.13. Amway
13.13.1. Company Overview, Business Information, Regional Presence
13.13.2. Product Portfolio Analysis
13.13.2.1. Product Details, Specification, Application
13.13.3. Revenue, Price, and Gross Margin (2017-2020)
13.13.4. Recent Developments and Strategies
13.14. Archer Daniels Midland
13.14.1. Company Overview, Business Information, Regional Presence
13.14.2. Product Portfolio Analysis
13.14.2.1. Product Details, Specification, Application
13.14.3. Revenue, Price, and Gross Margin (2017-2020)
13.14.4. Recent Developments and Strategies
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1
774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
0 Comments